Literature DB >> 9242673

Globin gene silencing in primary erythroid cultures. An inhibitory role for interleukin-6.

A E Ferry1, S B Baliga, C Monteiro, B S Pace.   

Abstract

There are numerous similarities between the erythroid and megakaryocytic lineages which suggest that commitment to either lineage occurs relatively late in hematopoiesis. Commitment toward megakaryocyte development requires obligatory silencing of erythroid-specific genes. Therefore, we investigated the effects of interleukin-6, a known inducer of thrombocyte production, on globin gene expression during erythroid differentiation. Studies in K562 cells demonstrated inhibition of gamma globin gene mRNA production and chain biosynthesis in the presence of exogenous interleukin-6 which was abrogated by anti-interleukin-6 monoclonal antibody. Similar studies in primary erythroid progenitors showed inhibition of burst-forming unit-erythroid colony formation when interleukin-6 was added late in cultures with decreased gamma and beta globin gene mRNA production. Protein binding studies demonstrated an increase in activator protein-1 binding to its consensus sequence by 24 h of interleukin-6 treatment. Inhibition of activator protein-1 gene activity had no effect on gamma gene silencing by interleukin-6. A potential interleukin-6 response element was identified in the gamma globin gene. Interleukin-6 treatment led to a rapid increase in protein binding to the target DNA sequence. These results suggest that interleukin-6 may play an important role in globin gene silencing during megakaryocytic lineage commitment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242673     DOI: 10.1074/jbc.272.32.20030

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection.

Authors:  David B Chou; Brian Sworder; Nicolas Bouladoux; Cindy N Roy; Amiko M Uchida; Michael Grigg; Pamela G Robey; Yasmine Belkaid
Journal:  J Leukoc Biol       Date:  2012-04-09       Impact factor: 4.962

2.  Anemia in frailty.

Authors:  Cindy N Roy
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

3.  Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells.

Authors:  Bryan J McCranor; Min Jung Kim; Nicole M Cruz; Qian-Li Xue; Alan E Berger; Jeremy D Walston; Curt I Civin; Cindy N Roy
Journal:  Blood Cells Mol Dis       Date:  2013-10-09       Impact factor: 3.039

4.  Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation.

Authors:  Jacqueline M Langdon; Saiah C Yates; Laurette K Femnou; Bryan J McCranor; Chris Cheadle; Qian-Li Xue; Sophie Vaulont; Curt I Civin; Jeremy D Walston; Cindy N Roy
Journal:  Am J Hematol       Date:  2014-02-24       Impact factor: 10.047

5.  Small Rab GTPase Rab7b promotes megakaryocytic differentiation by enhancing IL-6 production and STAT3-GATA-1 association.

Authors:  Donghua He; Taoyong Chen; Mingjin Yang; Xuhui Zhu; Chen Wang; Xuetao Cao; Zhen Cai
Journal:  J Mol Med (Berl)       Date:  2010-10-16       Impact factor: 4.599

6.  Role of STAT3 and GATA-1 interactions in gamma-globin gene expression.

Authors:  Xiao Yao; Sirisha Kodeboyina; Li Liu; James Dzandu; Jose Sangerman; Solomon F Ofori-Acquah; Betty S Pace
Journal:  Exp Hematol       Date:  2009-05-15       Impact factor: 3.084

7.  Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-alpha gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region.

Authors:  Pelagia Foka; Scott A Irvine; Feray Kockar; Dipak P Ramji
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

8.  Information exploration system for sickle cell disease and repurposing of hydroxyfasudil.

Authors:  Magbubah Essack; Aleksandar Radovanovic; Vladimir B Bajic
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

9.  Human fetal globin gene expression is regulated by LYAR.

Authors:  Junyi Ju; Ying Wang; Ronghua Liu; Yichong Zhang; Zhen Xu; Yadong Wang; Yupeng Wu; Ming Liu; Loretta Cerruti; Fengwei Zou; Chi Ma; Ming Fang; Renxiang Tan; Stephen M Jane; Quan Zhao
Journal:  Nucleic Acids Res       Date:  2014-08-04       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.